Data Foundry

Drug recalls 2016

Marcaine 0 — Class II drug recall D-0097-2017

Terminated recall by Hospira Inc., A Pfizer Company, reported 2016-10-19, distributed nationwide. Lack of Assurance of Sterility and Subpotent Drug: defect in glass vial prevented stopper from forming a seal

Recall numberD-0097-2017
Product typeDrug
ClassificationClass II
StatusTerminated
Voluntary or mandatedVoluntary
Recalling firmHospira Inc., A Pfizer Company, Lake Forest, IL, United States
Recall initiated2016-09-16
Classified2016-10-13
Reported by FDA2016-10-19
Terminated2019-07-31
DistributedNationwide (US)
Quantity4,768 vials
Reason classesforeign material, labeling, potency, sterility, packaging
NDC00409-0525, 00409-0525-01, 00409-0525-25, 00409-1250, 00409-1250-01, 00409-1250-25, 00409-1530, 00409-1530-01, 00409-1530-25, 00409-1559, 00409-1559-10, 00409-1559-18, 00409-1559-19, 00409-1559-30, 00409-1560, 00409-1560-10, 00409-1560-18, 00409-1560-19, 00409-1560-29, 00409-1582, 00409-1582-10, 00409-1582-18, 00409-1582-19, 00409-1582-29, 00409-1587 and 32 more
Lot numbers59310DD
Expiration dates2017-11-01

Product

Marcaine 0.5% (bupivacaine HCl) injection, USP, 250 mg/50 mL (5 mg/mL), 50 mL Multiple-Dose Vial, Rx only, Hospira, Inc., Lake Forest, IL 60045, NDC 0409-1610-50.

Reason for recall

Lack of Assurance of Sterility and Subpotent Drug: defect in glass vial prevented stopper from forming a seal allowing water to ingress and dilute the product causing it to be less than the labeled potency.

Machine access

This record, with every extracted code, the verbatim FDA record and provenance, is available from the recall API: GET https://api.data.aroqon.com/v1/recalls/D-0097-2017. Look up any UPC, UDI, NDC or lot with /v1/recalls/lookup?code=…. API docs · free and paid keys.

Source: U.S. Food and Drug Administration enforcement report via openFDA (CC0). Structured by Data Foundry (recall-structuring@2); last changed 2026-09-26. Not affiliated with or endorsed by FDA. Not medical or legal advice.